Amrid-D

Amrid-D may be available in the countries listed below.

Ingredient matches for Amrid-D

Miconazole

Miconazole is reported as an ingredient of Amrid-D in the following countries:

• Japan

International Drug Name Search

Becaplermin

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

D03AX,D03AX06

CAS registry number (Chemical Abstracts Service)

0165101-51-9

Chemical Formula

C1064-H1720-N324-O304-S18

Molecular Weight

24496

Therapeutic Category

Wound healing agent

Chemical Name

Recombinant human platelet-derived growth factor B (WHO)

Foreign Names

• Becaplerminum (Latin)
• Becaplermin (German)
• Bécaplermine (French)
• Becaplermina (Spanish)

Generic Names

• Becaplermin (OS: USAN, BAN)
• Bécaplermine (OS: DCF)
• Recombinant human platelet-derived growth factor B (IS: WHO)
• rhPDGF-BB (IS)
• RWJ 60235 (IS: Chiron)

Brand Names

• Regranex
  Ethicon, France; Janssen, Germany; Janssen, Israel; Janssen, Mexico; Janssen, Netherlands; Janssen, Slovakia; Janssen, Taiwan; Janssen-Cilag, Switzerland; Janssen-Cilag, United Kingdom; Janssen-Cilag International, Austria; Janssen-Ortho Inc., Canada; Laboratorios Dr Esteve, Spain

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Norflex

In the US, Norflex (orphenadrine systemic) is a member of the drug class skeletal muscle relaxants and is used to treat Migraine and Muscle Spasm.

US matches:

• Norflex


• Norflex Injection

Ingredient matches for Norflex

Orphenadrine

Orphenadrine citrate (a derivative of Orphenadrine) is reported as an ingredient of Norflex in the following countries:

• Australia


• Canada


• Costa Rica


• Dominican Republic


• El Salvador


• Finland


• Germany


• Greece


• Guatemala


• Honduras


• Kenya


• Luxembourg


• Malta


• New Zealand


• Panama


• Peru


• South Africa


• Sweden


• United States


• Venezuela


• Zimbabwe

International Drug Name Search

Humalog

See also: Generic Humalog KwikPen, Generic Humalog Pen

Humalog is a brand name of insulin lispro, approved by the FDA in the following formulation(s):

HUMALOG (insulin lispro recombinant - injectable; injection)

• 
  Manufacturer: LILLY
  
  Approval date: June 14, 1996
  
  Strength(s): 100 UNITS/ML ^[RLD]

Has a generic version of Humalog been approved?

No. There is currently no therapeutically equivalent version of Humalog available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Humalog. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Insulin analog formulations
  Patent 5,474,978
  Issued: December 12, 1995
  Inventor(s): Bakaysa; Diane L. & Brems; David N. & Frank; Bruce H. & Havel; Henry A. & Pekar; Allen H.
  Assignee(s): Eli Lilly and Company
  The present invention discloses a human insulin analog hexamer complex and formulations. More specifically, the present invention relates to various parenteral formulations, which comprise: human insulin analogs in a hexamer conformation, zinc ions, and at least three molecules of a phenolic derivative selected from the group consisting of m-cresol, phenol, or a mixture of m-cresol and phenol. The formulation provides a rapid onset of action.
  
  Patent expiration dates:
  
  
  • June 16, 2014
    
    ✓ 
    Patent use: HUMALOG IS AN INSULIN ANALOG THAT IS INDICATED IN THE TREATMENT OF PATIENTS WITH DIABETES MELLITUS FOR THE CONTROL OF HYPERGLYCEMIA
  
  



• 
  Insulin analogs modified at position 29 of the B chain
  Patent 5,514,646
  Issued: May 7, 1996
  Inventor(s): Chance; Ronald E. & DiMarchi; Richard D. & Frank; Bruce H. & Shields; James E.
  Analogs of human insulin modified at position 29 of the B chain thereof and, optionally, at other positions, have modified physico-chemical and pharmacokinetic properties and are useful in the treatment of hyperglycemia.
  
  Patent expiration dates:
  
  
  • May 7, 2013
    
    ✓ 
    Patent use: HUMALOG IS AN INSULIN ANALOG THAT IS INDICATED IN THE TREATMENT OF PATIENTS WITH DIABETES MELLITUS FOR THE CONTROL OF HYPERGLYCEMIA
  
  

See also...

• Humalog Consumer Information (Drugs.com)
• Humalog Cartridges Consumer Information (Wolters Kluwer)
• Humalog Vials Consumer Information (Wolters Kluwer)
• Humalog Consumer Information (Cerner Multum)
• Humalog Advanced Consumer Information (Micromedex)
• Humalog AHFS DI Monographs (ASHP)
• Insulin Lispro Cartridges Consumer Information (Wolters Kluwer)
• Insulin Lispro Vials Consumer Information (Wolters Kluwer)
• Insulin lispro Consumer Information (Cerner Multum)
• Lispro-PFC Advanced Consumer Information (Micromedex)
• Insulin lispro Subcutaneous Advanced Consumer Information (Micromedex)
• Insulin lispro, recombinant Subcutaneous Advanced Consumer Information (Micromedex)
• Insulin Lispro AHFS DI Monographs (ASHP)

Panangin

Panangin may be available in the countries listed below.

Ingredient matches for Panangin

Amino Acids

Aspartic Acid dipotassium and magnesium (a derivative of Aspartic Acid) is reported as an ingredient of Panangin in the following countries:

• China


• Estonia


• Georgia


• Lithuania


• Romania


• Russian Federation

Potassium

Potassium is reported as an ingredient of Panangin in the following countries:

• Vietnam

International Drug Name Search

Depolan

Depolan may be available in the countries listed below.

Ingredient matches for Depolan

Morphine

Morphine hydrochloride (a derivative of Morphine) is reported as an ingredient of Depolan in the following countries:

• Denmark


• Finland


• Sweden

Risperidone

Risperidone is reported as an ingredient of Depolan in the following countries:

• Greece

International Drug Name Search

Ametrex

Ametrex may be available in the countries listed below.

Ingredient matches for Ametrex

Paracetamol

Paracetamol is reported as an ingredient of Ametrex in the following countries:

• Colombia

International Drug Name Search